Cherry Tree Wealth Management, LLC Astrazeneca PLC Transaction History
Cherry Tree Wealth Management, LLC
- $422 Billion
- Q3 2024
A detailed history of Cherry Tree Wealth Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Cherry Tree Wealth Management, LLC holds 334 shares of AZN stock, worth $22,585. This represents 0.01% of its overall portfolio holdings.
Number of Shares
334
Previous 334
-0.0%
Holding current value
$22,585
Previous $26 Million
0.1%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding AZN
# of Institutions
1,360Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.25 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.84 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.52 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.49 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.29 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $210B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...